Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 8 results.
User Information
Export Records
  1. 1.   Safety, Tolerability, and Mechanisms of Antiretroviral Activity of Pegylated Interferon Alfa-2a in HIV-1-Monoinfected Participants: A Phase II Clinical Trial
  2. Asmuth, D. M.; Murphy, R. L.; Rosenkranz, S. L.; Lertora, J. J. L.; Kottilil, S.; Cramer, Y.; Chan, E. S.; Schooley, R. T.; Rinaldo, C. R.; Thielman, N.; Li, X. D.; Wahl, S. M.; Shore, J.; Janik, J.; Lempicki, R. A.; Simpson, Y.; Pollard, R. B.; Tea, A. C. T. G. A.
  3. Journal of Infectious Diseases. 2010, Jun 1; 201(11): 1686-1696.
  1. 2.   Interleukin-27, an Anti-HIV-1 Cytokine, Inhibits Replication of Hepatitis C Virus
  2. Frank, A. C.; Zhang, X. Z.; Katsounas, A.; Bharucha, J. P.; Kottilil, S.; Imamichi, T.
  3. Journal of Interferon and Cytokine Research. 2010, Jun; 30(6): 427-431.
  1. 3.   Hepatitis C Viral Kinetics During Treatment With Peg IFN-alpha-2b in HIV/HCV Coinfected Patients as a Function of Baseline CD4(+) T-Cell Counts
  2. Avidan, N. U.; Goldstein, D.; Rozenberg, L.; McLaughlin, M.; Ferenci, P.; Masur, H.; Buti, M.; Fauci, A. S.; Polis, M. A.; Kottilil, S.
  3. Jaids-Journal of Acquired Immune Deficiency Syndromes. 2009 52(4): 452-458.
  1. 4.   Human Immunodeficiency Virus and Hepatitis C Infections Induce Distinct Immunologic Imprints in Peripheral Mononuclear Cells
  2. Kottilil, S.; Yan, M. Y.; Reitano, K. N.; Zhang, X.; Lempicki, R.; Roby, G.; Daucher, M.; Yang, J.; Cortez, K. J.; Ghany, M.; Polis, M. A.; Fauci, A. S.
  3. Hepatology. 2009 50(1): 34-45.
  1. 5.   Comparison of the Abbott 7000 and Bayer 340 systems for measurement of hepatitis C virus load
  2. Highbarger, H. C.; Hu, Z. H.; Kottilil, S.; Metcalf, J. A.; Polis, M. A.; Vasudevachari, M. B.; Lane, H. C.; Dewar, R. L.
  3. Journal of Clinical Microbiology. 2007, Sep; 45(9): 2808-2812.
  1. 6.   Differential antiviral effect of PEG-interferon-alpha-2b on HIV and HCV in the treatment of HIV/HCV co-infected patients
  2. Neumann, A. U.; Polis, M. A.; Rozenberg, L.; Jackson, J. O.; Reitano, K. N.; McLaughlin, M.; Koratich, C.; Dewar, R. L.; Masur, H.; Haagmans, B. L.; Kottilil, S.
  3. Aids. 2007, Sep; 21(14): 1855-1865.
  1. 7.   Hepatic histologic response (HR) to combination therapy among HCV/HIV-coinfected individuals: Interferon induces HR independent of sustained virologic response (SVR)
  2. Wu, L.; Kottilil, S.; Lempicki, R.; Yang, J.; McLaughlin, M.; Hu, Z. H.; Koratich, C.; Reitano, K. N.; Rehm, C. A.; Masur, H.; Wood, B.; Kleiner, D. E.; Polis, M. A.
  3. Aids Research and Human Retroviruses. 2006, Nov; 22(11): 1091-1098.
  1. 8.   Gene expression profiles in hepatitis C virus (HCV) and HIV coinfection: Class prediction analyses before treatment predict the outcome of anti-HCV therapy among HIV-coinfected persons
  2. Lempicki, R. A.; Polis, M. A.; Yang, J.; McLaughlin, M.; Koratich, C.; Huang, D. W.; Fullmer, B.; Wu, L.; Rehm, C. A.; Masur, H.; Lane, H. C.; Sherman, K. E.; Fauci, A. S.; Kottilil, S.
  3. Journal of Infectious Diseases. 2006, Apr; 193(8): 1172-1177.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel